Lyra Therapeutics, Inc. (LYRA)
$0.01Close
SELLCRISIS · day 34
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $17,749
- Avg volume
- 10.2K
- Beta
- 0.70
- P/E (TTM)
- -0.00
- Short % float
- 0.31%
- Days to cover
- 1.7
- SI change
- +1.9%
- 1W
- -96.00%
- 1M
- -98.08%
- 3M
- -98.57%
- YTD
- -99.68%
- vs SPY 1W
- -94.81%
- vs SPY 1M
- -101.40%
- vs SPY 3M
- -100.96%
- vs SPY YTD
- -111.44%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- CTXRBUYCitius Pharmaceuticals, Inc.CRISISQ -11$0.58-3.33%
- AUTLBUYAutolus Therapeutics plcRECOVERYQ -9$2.34-2.90%
- RPIDSELLRapid Micro Biosystems, Inc.CRISISQ -14$1.66-1.19%
- FHTXBUYFoghorn Therapeutics Inc.RECOVERYQ 4$6.87-2.83%
- SSIISELLSS Innovations International, Inc.RECOVERYQ 17$3.50-2.51%
- ESTASELLEstablishment Labs Holdings Inc.CRISISQ 17$72.06-0.84%
- INCRBUYInterCure Ltd.RECOVERYQ 7$5.48+28.64%
- OMERBUYOmeros CorporationBULLQ 18$19.32+0.26%
- CGONBUYCG Oncology, Inc. Common stockBULLQ 32$78.23-1.98%
- DNLIBUYDenali Therapeutics Inc.RECOVERYQ 10$24.20-2.89%
- MAZESELLMaze Therapeutics, Inc.RECOVERYQ 40$29.60+0.58%
- CNTBBUYConnect Biopharma Holdings LimitedRECOVERYQ -12$2.30-2.54%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 4
- VALUE
- 3
- GROWTH
- 37
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-
REV YoY-
ROE-
EPS YoY-
ROA-80.1%
GROSS100
OP-7794
NET-7266
[VALUATION]
P/E TTM-0.00
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B-0.01
P/FCF-
EV/EBITDA-0.52
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO1.71
ND/EBITDA-
BETA0.70
Company news
Loading headlines…